Prop. 71 photo
“Having worked as a consultant for a biotechnology software startup, I have seen the challenges of developing new medical treatments up close. Thus, I have a degree of understanding of what CIRM is facing. While new therapies or cures have yet to emerge from CIRM-funded research, knowledge of stem cell function and disease processes has advanced dramatically.
“However, CIRM could also more effectively communicate research advances to the general public, who remain largely uninformed about its progress, achievements and future goals. Despite this communication gap, I believe the research the CIRM has conducted lays the groundwork for treatments that will hopefully be available in the near future.”